|
Treatment
|
CD19
+
LAG3
+
(%)
|
|---|
|
Control
|
6.9 ± 0.4
|
|
CBD
|
7.9 ± 0.9
|
|
MOG35-55
|
6.0 ± 0.4
|
|
CBD + MOG35-55
|
5.7 ± 0.9
|
- APC/TMOG co-cultures were stimulated with MOG35-55 and CBD. The level of LAG3 was measured by flow cytometry and is expressed as mean ± SEM% of CD19+ B cells positive for LAG3. ANOVA F(3,8) = 1.8, P > 0.05 (n = 3).